Synlett 2025; 36(11): 1545-1547
DOI: 10.1055/a-2569-9486
letter

Enantioselective Synthesis of Fmoc-Protected (2S,3R)-3,4-Dimethyl-2-(methylamino)pentanoic Acid

a   Abzena, 360 George Patterson Blvd, Bristol, PA 19007, USA
,
Nurul Ansari
a   Abzena, 360 George Patterson Blvd, Bristol, PA 19007, USA
,
Jerry Taylor
a   Abzena, 360 George Patterson Blvd, Bristol, PA 19007, USA
,
Francisco Velazquez
a   Abzena, 360 George Patterson Blvd, Bristol, PA 19007, USA
,
Thomas Nittoli
b   Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA
› Institutsangaben


Abstract

The first enantioselective synthesis of the Fmoc-protected rare amino acid, 3,4-dimethyl-2-(methylamino)pentanoic acid, is disclosed. The synthesis utilized the chiral oxazolidinone to introduce the first chiral center (>95:5 ee), and then swapped the auxiliary to Ellman’s N-sulfinylimine for setting up the chiral α-amino group (95:5 dr). The newly formed chiral centers were confirmed by X-ray crystallography. With this unique amino acid on hand, naturally occurring macrocyclic peptides will become synthetically accessible.

Supporting Information



Publikationsverlauf

Eingereicht: 06. März 2025

Angenommen nach Revision: 31. März 2025

Accepted Manuscript online:
31. März 2025

Artikel online veröffentlicht:
15. Mai 2025

© 2025. Thieme. All rights reserved

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany